194 related articles for article (PubMed ID: 27092079)
21. Natriuretic peptide receptor-C activation attenuates angiotensin II-induced enhanced oxidative stress and hyperproliferation of aortic vascular smooth muscle cells.
Madiraju P; Hossain E; Anand-Srivastava MB
Mol Cell Biochem; 2018 Nov; 448(1-2):77-89. PubMed ID: 29417337
[TBL] [Abstract][Full Text] [Related]
22. Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats.
Savoia C; Tabet F; Yao G; Schiffrin EL; Touyz RM
J Hypertens; 2005 May; 23(5):1037-45. PubMed ID: 15834290
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells.
Hong HJ; Chan P; Liu JC; Juan SH; Huang MT; Lin JG; Cheng TH
Cardiovasc Res; 2004 Jan; 61(1):159-68. PubMed ID: 14732213
[TBL] [Abstract][Full Text] [Related]
24. Alpha1beta1 and integrin-linked kinase interact and modulate angiotensin II effects in vascular smooth muscle cells.
Moraes JA; Frony AC; Dias AM; Renovato-Martins M; Rodrigues G; Marcinkiewicz C; Assreuy J; Barja-Fidalgo C
Atherosclerosis; 2015 Dec; 243(2):477-85. PubMed ID: 26520903
[TBL] [Abstract][Full Text] [Related]
25. Vasodilator-derived nitric oxide inhibits fetal calf serum- and angiotensin-II-induced growth of renal arteriolar smooth muscle cells.
Dubey RK
J Pharmacol Exp Ther; 1994 Apr; 269(1):402-8. PubMed ID: 8169847
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation.
Aoki H; Izumo S; Sadoshima J
Circ Res; 1998 Apr; 82(6):666-76. PubMed ID: 9546375
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II induces reorganization of the actin cytoskeleton and myosin light-chain phosphorylation in podocytes through rho/ROCK-signaling pathway.
Wang S; Chen C; Su K; Zha D; Liang W; Hillebrands JL; Goor Hv; Ding G
Ren Fail; 2016; 38(2):268-75. PubMed ID: 26652313
[TBL] [Abstract][Full Text] [Related]
28. RhoA/ROCK signaling regulates smooth muscle phenotypic modulation and vascular remodeling via the JNK pathway and vimentin cytoskeleton.
Tang L; Dai F; Liu Y; Yu X; Huang C; Wang Y; Yao W
Pharmacol Res; 2018 Jul; 133():201-212. PubMed ID: 29791873
[TBL] [Abstract][Full Text] [Related]
29. B-type natriuretic peptide inhibits angiotensin II-induced proliferation and migration of pulmonary arterial smooth muscle cells.
Hsu JH; Liou SF; Yang SN; Wu BN; Dai ZK; Chen IJ; Yeh JL; Wu JR
Pediatr Pulmonol; 2014 Aug; 49(8):734-44. PubMed ID: 24167111
[TBL] [Abstract][Full Text] [Related]
30. Arachidonic acid-dependent activation of a p22(phox)-based NAD(P)H oxidase mediates angiotensin II-induced mesangial cell protein synthesis and fibronectin expression via Akt/PKB.
Block K; Ricono JM; Lee DY; Bhandari B; Choudhury GG; Abboud HE; Gorin Y
Antioxid Redox Signal; 2006; 8(9-10):1497-508. PubMed ID: 16987006
[TBL] [Abstract][Full Text] [Related]
31. DL0805-2, a novel indazole derivative, relaxes angiotensin II-induced contractions of rat aortic rings by inhibiting Rho kinase and calcium fluxes.
Yuan TY; Chen YC; Zhang HF; Li L; Jiao XZ; Xie P; Fang LH; Du GH
Acta Pharmacol Sin; 2016 May; 37(5):604-16. PubMed ID: 27041459
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of smooth muscle 22α facilitates angiotensin II-induced ROS production via activation of the PKCδ-P47phox axis through release of PKCδ and actin dynamics and is associated with hypertrophy and hyperplasia of vascular smooth muscle cells in vitro and in vivo.
Lv P; Miao SB; Shu YN; Dong LH; Liu G; Xie XL; Gao M; Wang YC; Yin YJ; Wang XJ; Han M
Circ Res; 2012 Aug; 111(6):697-707. PubMed ID: 22798525
[TBL] [Abstract][Full Text] [Related]
33. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways.
Rupérez M; Rodrigues-Díez R; Blanco-Colio LM; Sánchez-López E; Rodríguez-Vita J; Esteban V; Carvajal G; Plaza JJ; Egido J; Ruiz-Ortega M
Hypertension; 2007 Aug; 50(2):377-83. PubMed ID: 17592071
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
[TBL] [Abstract][Full Text] [Related]
35. Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Role of cGMP in the regulation of the plasminogen system.
Bouchie JL; Hansen H; Feener EP
Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1771-9. PubMed ID: 9812917
[TBL] [Abstract][Full Text] [Related]
36. NLRP3 Gene Deletion Attenuates Angiotensin II-Induced Phenotypic Transformation of Vascular Smooth Muscle Cells and Vascular Remodeling.
Ren XS; Tong Y; Ling L; Chen D; Sun HJ; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Physiol Biochem; 2017; 44(6):2269-2280. PubMed ID: 29262411
[TBL] [Abstract][Full Text] [Related]
37. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice.
Matsuno K; Yamada H; Iwata K; Jin D; Katsuyama M; Matsuki M; Takai S; Yamanishi K; Miyazaki M; Matsubara H; Yabe-Nishimura C
Circulation; 2005 Oct; 112(17):2677-85. PubMed ID: 16246966
[TBL] [Abstract][Full Text] [Related]
38. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells.
Kyaw M; Yoshizumi M; Tsuchiya K; Kirima K; Tamaki T
Hypertens Res; 2001 May; 24(3):251-61. PubMed ID: 11409648
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II receptor coupling to phospholipase D is mediated by the betagamma subunits of heterotrimeric G proteins in vascular smooth muscle cells.
Ushio-Fukai M; Alexander RW; Akers M; Lyons PR; Lassègue B; Griendling KK
Mol Pharmacol; 1999 Jan; 55(1):142-9. PubMed ID: 9882708
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells.
Touyz RM; Yao G; Viel E; Amiri F; Schiffrin EL
J Hypertens; 2004 Jun; 22(6):1141-9. PubMed ID: 15167449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]